Sarepta Therapeutics Inc (SRPT)
127.39
+3.14
(+2.53%)
USD |
NASDAQ |
Apr 25, 16:00
127.36
-0.03
(-0.02%)
After-Hours: 20:00
Sarepta Therapeutics Free Cash Flow: -588.34M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -588.34M |
| September 30, 2023 | -615.20M |
| June 30, 2023 | -534.00M |
| March 31, 2023 | -469.75M |
| December 31, 2022 | -357.60M |
| September 30, 2022 | -290.88M |
| June 30, 2022 | -350.03M |
| March 31, 2022 | -389.18M |
| December 31, 2021 | -483.97M |
| September 30, 2021 | -653.28M |
| June 30, 2021 | -783.19M |
| March 31, 2021 | -794.93M |
| December 31, 2020 | 25.26M |
| September 30, 2020 | 47.36M |
| June 30, 2020 | 233.99M |
| March 31, 2020 | 265.07M |
| December 31, 2019 | -516.09M |
| September 30, 2019 | -475.03M |
| June 30, 2019 | -532.66M |
| March 31, 2019 | -563.81M |
| December 31, 2018 | -449.82M |
| September 30, 2018 | -345.41M |
| June 30, 2018 | -276.58M |
| March 31, 2018 | -238.12M |
| December 31, 2017 | -253.21M |
| Date | Value |
|---|---|
| September 30, 2017 | -302.21M |
| June 30, 2017 | -298.33M |
| March 31, 2017 | -254.02M |
| December 31, 2016 | -252.69M |
| September 30, 2016 | -200.91M |
| June 30, 2016 | -186.94M |
| March 31, 2016 | -172.29M |
| December 31, 2015 | -154.30M |
| September 30, 2015 | -150.40M |
| June 30, 2015 | -150.81M |
| March 31, 2015 | -165.75M |
| December 31, 2014 | -155.36M |
| September 30, 2014 | -145.01M |
| June 30, 2014 | -118.35M |
| March 31, 2014 | -86.89M |
| December 31, 2013 | -68.47M |
| September 30, 2013 | -57.50M |
| June 30, 2013 | -43.83M |
| March 31, 2013 | -36.99M |
| December 31, 2012 | -30.84M |
| September 30, 2012 | -29.69M |
| June 30, 2012 | -29.65M |
| March 31, 2012 | -24.89M |
| December 31, 2011 | -25.98M |
| September 30, 2011 | -21.94M |
Free Cash Flow Range, Past 5 Years
-794.93M
Minimum
Mar 2021
265.07M
Maximum
Mar 2020
-382.23M
Average
-475.03M
Median
Sep 2019
Free Cash Flow Benchmarks
| PTC Therapeutics Inc | -279.04M |
| Vertex Pharmaceuticals Inc | 3.279B |
| Regenxbio Inc | -228.37M |
| CytomX Therapeutics Inc | -56.88M |
| Apellis Pharmaceuticals Inc | -595.51M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -54.66M |
| Cash from Investing (Quarterly) | -64.36M |
| Cash from Financing (Quarterly) | 1.943M |
| Free Cash Flow Per Share (Quarterly) | -0.7102 |
| Free Cash Flow to Equity (Quarterly) | -74.94M |
| Free Cash Flow to Firm (Quarterly) | -73.70M |
| Free Cash Flow Yield | -5.00% |